Dissecting Immune Determinants in Lesional Skin of Cutaneous T-Cell Lymphoma During Mogamulizumab Therapy
Open Access
Abstract
Background: Mycosis fungoides (MF) and Sézary syndrome (SS) are the predominant cutaneous T-cell lymphomas. Although malignant T cells in MF/SS overexpress CCR4 and respond to the anti-CCR4 antibody mogamulizumab, skin response rates vary. We hypothesized that immune components within the tumor microenvironment contribute to differential outcomes. Methods: Imaging mass cytometry with a 37-antibody panel was used to characterize immune and structural elements in FFPE tissues from sixteen MF/SS patients (6 MF, 10 SS) treated with Mogamulizumab, including seven skin responders and nine non-responders. Single-cell phenotyping and spatial analyses were performed using the Visiopharm® Phenoplex™ platform, with supervision. Results: We identified 68,974 cells pre-treatment and 58,852 cells post-treatment. Malignant CD4+ T cells showed reduced baseline CD27, CD103, CD25, and ICOS expression compared with non-malignant CD4+ cells. Baseline MF lesions were enriched for IL-13+ and CD103+ malignant T cells, whereas SS lesions contained higher proportions of CD27+ and LAG3+ cells. IL 13+ malignant cells decreased after treatment, most prominently in MF. Myeloid profiles differed by disease and response: MF lesions exhibited baseline enrichment of M1-like macrophages (CD86+, HLA-DR+), while SS lesions were predominantly M2-polarized macrophages (CD163+, CD206+). Responders showed increased M1-like macrophages, whereas non-responders displayed reduced M1-features. An increase in DC3-like cells was observed in non-responders following treatment. Conclusions: This single-cell spatial atlas reveals shared and subtype-specific immune features in MF/SS. Th2-skewed malignant T-cell status and myeloid polarization correlate with clinical response, supporting their potential as spatial biomarkers for patient stratification in mogamulizumab therapy.Keywords
Funding Information
- University of Texas MD Anderson Cancer Center (2023-00062067)
- University of Texas MD Anderson Cancer Center (NIH P30CA16672)
- Fred Pearce Fund (122209)
This publication has 32 references indexed in Scilit:
- PENGUIN: A rapid and efficient image preprocessing tool for multiplexed spatial proteomicsComputational and Structural Biotechnology Journal, 2024
- Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex imagesSTAR Protocols, 2024
- cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids modelEuropean Journal of Immunology, 2024
- Tape stripped stratum corneum samples are suitable for diagnosis and comprehensive proteomic investigation in mycosis fungoidesProteomics – Clinical Applications, 2023
- A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti–PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL)Journal of Investigative Dermatology, 2020
- Tissue-Resident Macrophage Ontogeny and HomeostasisImmunity, 2016
- Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In VivoJournal of Investigative Dermatology, 2014
- A Three-Dimensional Atlas of Human Dermal Leukocytes, Lymphatics, and Blood VesselsJournal of Investigative Dermatology, 2014
- Tumor-induced modulation of dendritic cell functionCytokine & Growth Factor Reviews, 2008
- Mycosis fungoides-type cutaneous T-cell lymphoma arising before 30 years of ageJournal of the American Academy of Dermatology, 1992